01

October 01, 2026 To, The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Dear Sir/ Madam, Trading Symbol: ZOTA Sub: Intimation of Acquisition of 20,20,000 equity shares of M/s Curexis Ventures Private Limited , Wholly Owned Subsidiary of the Company, by way of subscription to the right issue.

Page 1

02

we, M/s Zota Health Care Limited (the “Company”) , would like to inform you that the Company has acquired 20,20,000 equity shares of M/s Curexis Ventures Private Limited, Wholly Owned Subsidiary (“WOS”) of the Company, by way of subscription to the right issue.

Page 1

03

Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired?

Page 2

04

If yes, nature of interest and details thereof and whether the same is done at “arm’s length” No, the acquisition does not fall within the ambit of related party transactions.

Page 2

05

Industry to which the entity being acquired belongs Pharmaceutical Objects and effects of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity);

Page 2